Retinoic acid modulates peritoneal macrophage function and distribution to enhance antibacterial defense during

Yujuan Qin1,2, Xi Wang2,3, Xiamin Zhang1,4

  • 1Graduate School, Youjiang Medical University for Nationalities, Baise, China.

PubMed
Abstract

Insights

Retinoic acid (RA) boosts macrophage immune defense against bacterial infections by enhancing phagocytosis and recruitment. RA-loaded nanoparticles offer sustained therapeutic effects for inflammation and infection management.

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • Peritoneal macrophages (LPMs and SPMs) are crucial for immune defense during inflammation.
  • Molecular mechanisms of macrophage response to retinoic acid (RA) are not fully understood.
  • Investigating RA's role in modulating macrophage function during bacterial infections.

Purpose of the Study:

  • Elucidate the role of RA in macrophage function, distribution, and immune responses.
  • Assess RA's impact on macrophage phagocytosis and population dynamics.
  • Explore sustained RA delivery using nanoparticle formulations.

Main Methods:

  • Established a murine model of peritonitis using Escherichia coli.
  • Assessed macrophage phagocytic capacity, population dynamics, and transcriptomic profiles.
  • Utilized immunofluorescence, flow cytometry, RNA sequencing, qPCR, and RA-loaded ZIF-8 nanoparticles.

Main Results:

  • RA significantly enhanced macrophage phagocytic activity and delayed functional decline.
  • RA promoted SPM recruitment and upregulated leukocyte migration and cell adhesion pathways.
  • RA-loaded nanoparticles demonstrated prolonged RA retention and sustained effects.

Conclusions:

  • RA enhances antibacterial defense by modulating macrophage activity.
  • RA influences distinct gene expression profiles in macrophage subpopulations.
  • RA and its nanoparticle formulations show therapeutic potential for bacterial infections and inflammation.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
111
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.7K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
113
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
103